Skip to main content

Table 5 Number and percentage of two groups of asthmatic subjects under combination therapy and different type of drugs used and percentage of patients using each type of drug

From: Improvement in symptoms and pulmonary function of asthmatic patients due to their treatment according to the Global Strategy for Asthma Management (GINA)

Type of Drugs Usual care Gr. Intervention Gr.
  Beginning End Beginning End
  n % n % n % n %
OBA+OCS+OT+IBA 6 25.0 5 20.8 7 27.0 1 3.8
OCS+OT+IBA 0 0.0 0 0.0 0 0.0 1 3.8
OBA+ OT+IBA +ICS 1 4.2 1 4.2 0 0.0 0 0.0
OT+IBA 0 0.0 5 20.8 5 19.2 0 0.0
OT+IBA+ ICS 5 20.9 2 8.3 2 7.7 2 7.7
LAIBA+ICS 0 0.0 1 4.2 1 3.8 4 15.4
IBA+AH 2 8,3 2 8.3 0 0.0 3 11.5
IBA+ ICS 0 0.0 2 8.3 0 0.0 1 3.8
AH+ICS 0 0.0 0 0.0 4 15.4 2 7.7
ICS only 0 0.0 2 8.3 0 0.0 1 3.8
IBA only 4 16.7 2 8.3 3 11.5 11 42.0
  1. n: number, %: percentage of patients using each type of drug, OBA; oral beta agonist, OCS; oral corticosteroid, OT; oral theophylline, IBA; inhaled beta agonist, ICS; inhaled corticosteroid, LAIB; long acting inhaled beta agonist, AH; anti histamine